Lucia Da Ros

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Absolute quantification of cell-free microRNAs in cancer patients

Manuela Ferracin, Laura Lupini, Irene Salamon et al. · Oncotarget · 2015 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17

Early Detection of Impaired Glucose Tolerance in Patients with Cystic Fibrosis and Predisposition Factors

Jesus-Maria Garagorri, G Rodríguez, Lucia Da Ros et al. · Journal of Pediatric Endocrinology and Metabolism · 2001 · 79 citations

Medicine, Endocrinology, Genetics +17

Pregnancy After Breast Cancer in Young <i>BRCA </i>Carriers

Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto et al. · JAMA · 2023 · 54 citations · Full text

Medicine, Obstetrics, Oncology +16

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

Patrizia Vici, Laura Pizzuti, Isabella Sperduti et al. · Oncotarget · 2016 · 43 citations · Full text

Medicine, Oncology, Breast Oncology +7